Literature DB >> 22032403

Dermatitis herpetiformis in China: a report of 22 cases.

F Zhang1, B Yang, Y Lin, S Chen, G Zhou, G Wang, X Chen, Y Zhang, H Tian, M Yu, Z Shi, D Zhang.   

Abstract

BACKGROUND: Although dermatitis herpetiformis (DH) is a relatively common disease in Caucasian populations, it is very rare in the Far East, including China.
OBJECTIVES: To investigate the clinical, histological and immunopathological characteristics of Chinese patients with DH.
METHODS: The clinical data and serum samples of patients with DH diagnosed at Shandong Provincial Institute of Dermatology and Venereology from 2006 to 2010 were collected. Anti-endomysium antibodies (EMA) and anti-tissue transglutaminase (tTG) antibodies were tested using indirect immunofluorescence and enzyme-linked immunosorbent assay respectively. Biopsies of small intestine were performed in those patients who had given informed consent.
RESULTS: The study group consisted of 22 patients with DH. The male to female ratio was 2.1:1; the average age was 44 years. Five patients reported mild gastrointestinal symptoms. Dapsone was used to treat 14 patients, who achieved rapid relief. Direct immunofluorescence showed granular IgA deposits at the papillary tips and/or basement membrane zone in 95.5% (21/22) patients. Fibrillar IgA deposition limited to the papillary tips was also seen in one patient (4.5%). IgA antibodies against EMA and tTG were found in 50% (8/16) and 62.5% (10/16) of patient sera respectively. Small-intestinal biopsies of two patients confirmed the presence of coeliac disease.
CONCLUSIONS: The clinical, histological and immunopathological characteristics of Chinese patients with DH are similar to those seen in Caucasian populations. The positive rates of anti-EMA and anti-tTG antibodies were lower compared with those seen in Western countries. DH is not extremely rare in China and should be actively investigated.
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2011        PMID: 22032403     DOI: 10.1111/j.1468-3083.2011.04204.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  7 in total

Review 1.  Recent advances in dermatitis herpetiformis.

Authors:  Kimiko Nakajima
Journal:  Clin Dev Immunol       Date:  2012-07-02

2.  Granular Deposits of IgA in the Skin of Coeliac Patients Without Dermatitis Herpetiformis: A Prospective Multicentric Analysis.

Authors:  Emiliano Antiga; Roberto Maglie; Gabriele Lami; Alessandro Tozzi; Veronica Bonciolini; Francesca Calella; Beatrice Bianchi; Elena Del Bianco; Daniela Renzi; Edoardo Mazzarese; Antonino S Calabrò; Marzia Caproni
Journal:  Acta Derm Venereol       Date:  2021-02-02       Impact factor: 3.875

Review 3.  Current Concepts of Dermatitis Herpetiformis.

Authors:  Teea Salmi; Kaisa Hervonen
Journal:  Acta Derm Venereol       Date:  2020-02-12       Impact factor: 3.875

Review 4.  Dermatitis Herpetiformis: Novel Perspectives.

Authors:  Emiliano Antiga; Roberto Maglie; Lavinia Quintarelli; Alice Verdelli; Diletta Bonciani; Veronica Bonciolini; Marzia Caproni
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

Review 5.  Dermatitis Herpetiformis: An Update on Diagnosis and Management.

Authors:  Timo Reunala; Kaisa Hervonen; Teea Salmi
Journal:  Am J Clin Dermatol       Date:  2021-05       Impact factor: 7.403

Review 6.  Antigen recognition in the pathogenesis of immunoglobulin A-related autoimmune bullous diseases.

Authors:  Zhiliang Li; Ke Jing; Suo Li; Suying Feng
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837

7.  Female Patients with Dermatitis Herpetiformis Show a Reduced Diagnostic Delay and Have Higher Sensitivity Rates at Autoantibody Testing for Celiac Disease.

Authors:  Emiliano Antiga; Veronica Bonciolini; Simone Cazzaniga; Mauro Alaibac; Antonino Salvatore Calabrò; Carla Cardinali; Emanuele Cozzani; Angelo Valerio Marzano; Giuseppe Micali; Tarcisio Not; Pietro Quaglino; Camilla Vassallo; Luigi Naldi; Marzia Caproni
Journal:  Biomed Res Int       Date:  2019-12-29       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.